Wellbutrin Does NOT Have Anticholinergic Activity
Bupropion (Wellbutrin) does not act as an anticholinergic agent—in fact, it has minimal to no anticholinergic effects, which is one of its key advantages over tricyclic antidepressants. 1
Mechanism of Action
According to the FDA label, bupropion's mechanism involves:
- Noradrenergic and dopaminergic activity through relatively weak inhibition of norepinephrine and dopamine reuptake
- No anticholinergic properties
- No monoamine oxidase inhibition
- No serotonin reuptake inhibition 1
Clinical Significance: Why This Matters
The absence of anticholinergic effects is a major clinical advantage of bupropion compared to older antidepressants:
Side Effect Profile
- Minimal anticholinergic effects account for bupropion being generally well tolerated 2
- Causes fewer anticholinergic side effects than tricyclic antidepressants (TCAs) 3, 4
- The most common side effect is dry mouth, but this occurs through a different mechanism than anticholinergic activity 2
Comparative Safety
Clinical practice guidelines note that bupropion is associated with:
- Lower rates of sexual adverse events compared to SSRIs 5, 6
- Better tolerability in elderly patients who can receive full adult doses 4
- Avoidance of typical anticholinergic toxicity (urinary retention, confusion, constipation, blurred vision) that occurs with drugs having true anticholinergic properties 7
Common Pitfall to Avoid
Do not confuse "dry mouth" with anticholinergic activity. While dry mouth is the most common side effect of bupropion 2, this does not indicate anticholinergic mechanism. Many medications cause dry mouth through various non-anticholinergic pathways.
The evidence consistently demonstrates that bupropion's lack of anticholinergic properties makes it particularly suitable for patients who cannot tolerate anticholinergic side effects, including elderly patients at risk for cognitive impairment, delirium, and functional decline associated with anticholinergic burden 7.